Sage Journals: Discover world-class research

Open access

Brief report

First published 2021-3

Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors

Mei Qiu, Liang-Liang Ding, Miao Zhang [...]

Diabetes & Vascular Disease Research

Free access

Research article

First published 2012-4

Effects of SGLT2 inhibitors on cardiovascular outcomes

Celine Foote, Vlado Perkovic, Bruce Neal

Diabetes & Vascular Disease Research

Free access

Review article

First published 2016-12

The renal effects of SGLT2 inhibitors and a mini-review of the literature

Vasileios Andrianesis, Spyridoula Glykofridi, John Doupis

Therapeutic Advances in Endocrinology and Metabolism

Open access

Research article

First published 2024

Impact of SGLT2 Inhibitors on Left Ventricular Remodeling in Diabetic Patients with Acute Myocardial Infarction

Jun Wan, Feng Xu, Heping Zuo [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Review article

First published 2015-5

Empagliflozin,an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

John R. White

Annals of Pharmacotherapy

Open access

Research article

First published 2021-7

SGLT2 inhibition does not reduce glucose absorption during experimental peritoneal dialysis

Giedre Martus, Karin Bergling, Javier de Arteaga [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Open access

Review article

First published 2021

The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction

Michael V. Genuardi, Paul J. Mather

Therapeutic Advances in Cardiovascular Disease

Retricted access

Research article

First published 2026

Effect of SGLT2 Inhibitors on Atrial Electromechanical Delay in Patients with Type 2 Diabetes

Muhammed Erzurum, Mehmet Ali Felekoğlu, Nadire Isık Erol Algül [...]

Angiology

Retricted access

Research article

First published 2025

Impact of Pharmacist Intervention on Utilization of SGLT2 Inhibitors in Patients With Heart Failure With an Ejection Fraction Greater than 40%

Leanne Bockstruck, Kathryn Krei, Danielle Bozzardi-Jerome [...]

Journal of Pharmacy Practice

Retricted access

Review article

First published 2018-12

Renal and Cardiac Implications of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors: The State of the Science

Joseph E. Cruz, Tania Ahuja, Mary Barna Bridgeman

Annals of Pharmacotherapy

Search results